Half Year 2023 Transgene SA Earnings Call Transcript

Sep 20, 2023 / 04:00PM GMT
Operator

Hello, and welcome to the Transgene First Half 2023 Financial Results and Business Update Call. Please note, this conference is being recorded. (Operator Instructions) . I will now hand you over to your host, Lucie Larguier, to begin today’s conference. Thank you.

Lucie Larguier – Transgene SA – VP of Corporate Communication & IR

Thank you, [Francois]. Hello, everyone, I’m Lucie, Director of IR Transgene. I have the pleasure today to introduce you to Dr. Alessandro Riva, our Chairman and CEO along with several members of the Executive Committee. So you will have Eric Quéméneur, our CFO; Maud Brandely, Chief Medical Officer; Jean-Philippe Del, CFO; and Christophe Ancel, VP Pharmaceutical Operations. We will review today’s news regarding on the progress of the first half of this year and answer any questions you may have.

Before I turn over the call to Alessandro, I’d like to remind everyone that today’s discussion contains forward-looking statements, which are subject to numerous risks and uncertainties. If you listen to this webcast via the

MORE IN INSIDE INVESTMENT NEWS

Cerebras stock Plunges 14%: Alpha Opportunity or IPO Warning?

Published: Thursday, August 13, 2026 · 2:04 PM

Tencent’s Alpha Drive: Gaming Rebound Fuels Growth Amid AI Push

Published: Wednesday, August 12, 2026 · 5:18 AM